Research has found fidaxomicin, an antibiotic usually used to treat bowel infections, prevents growth of resistant strains of Mycobacterium tuberculosis (MTb) in the lab. Published in the Journal of Medical Microbiology, the research found that fidaxomicin was more effective than existing tuberculosis (TB) medication at preventing growth of the bacterium that causes TB. Researchers compared […]